Literature DB >> 23218608

Biosimilars in dermatology: starting with infliximab.

L Puig1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23218608     DOI： 10.1016/j.ad.2012.10.002

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN： 0001-7310


× No keyword cloud information.
  3 in total

Review 1.  Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence.

Authors:  Ira Jacobs; Danielle Petersel; Leah Isakov; Sadiq Lula; K Lea Sewell
Journal:  BioDrugs       Date:  2016-12       Impact factor: 5.807

Review 2.  Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published Evidence.

Authors:  Ira Jacobs; Danielle Petersel; Lesley G Shane; Chee-Keng Ng; Carol Kirchhoff; Gregory Finch; Sadiq Lula
Journal:  BioDrugs       Date:  2016-12       Impact factor: 5.807

Review 3.  Biosimilars: potential implications for clinicians.

Authors:  Misty G Eleryan; Sophia Akhiyat; Monica Rengifo-Pardo; Alison Ehrlich
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-06-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.